Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPE Trial: Combination Therapy of Hypertension to Prevent Cardiovascular Events
NCT00135551Phase 4Completed
- Start
- May 2003
- Primary completion
- May 2010
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised trial of benidipine in hypertension (HTN) (3 arms). Primary endpoints: Composite of fatal and non-fatal cardiovascular events and Achievement of target blood pressure (< 140 mmHg/90 mmHg). Started May 2003; status: completed.
02
Drugs
benidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00135551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135551.